Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Blood Cancer Journal, Published online: 27 September 2023; doi:10.1038/s41408-023-00923-6Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Source: Blood Cancer Journal - September 27, 2023 Category: Hematology Authors: Thomas Martin Meletios-Athanasios Dimopoulos Joseph Mikhael Kwee Yong Marcelo Capra Thierry Facon Roman Hajek Ivan Špička Ross Baker Kihyun Kim Gracia Martinez Chang-Ki Min Ludek Pour Xavier Leleu Albert Oriol Youngil Koh Kenshi Suzuki France Casca Sand Source Type: research